Cargando…

Prevalence and Characteristics of Interventional Trials Conducted Exclusively in Elderly Persons: A Cross-Sectional Analysis of Registered Clinical Trials

BACKGROUND: Elderly patients represent the greatest consumers of healthcare per capita but have historically been underrepresented in clinical trials. It is unknown how many trials are designed to focus exclusively on elderly patients. OBJECTIVE: To define the prevalence of interventional trials tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourgeois, Florence T., Olson, Karen L., Tse, Tony, Ioannidis, John P. A., Mandl, Kenneth D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873036/
https://www.ncbi.nlm.nih.gov/pubmed/27196289
http://dx.doi.org/10.1371/journal.pone.0155948
_version_ 1782432826078003200
author Bourgeois, Florence T.
Olson, Karen L.
Tse, Tony
Ioannidis, John P. A.
Mandl, Kenneth D.
author_facet Bourgeois, Florence T.
Olson, Karen L.
Tse, Tony
Ioannidis, John P. A.
Mandl, Kenneth D.
author_sort Bourgeois, Florence T.
collection PubMed
description BACKGROUND: Elderly patients represent the greatest consumers of healthcare per capita but have historically been underrepresented in clinical trials. It is unknown how many trials are designed to focus exclusively on elderly patients. OBJECTIVE: To define the prevalence of interventional trials that study exclusively elderly persons and describe the characteristics of these trials, including their distribution across conditions most prevalent in the elderly. DESIGN: All interventional clinical trials enrolling exclusively elderly patients (≥65 years), conducted primarily in high-income countries, and initiated between 2006 and 2014, identified through ClincialTrials.gov. MAIN MEASURES: Trials were identified and characterized according to design features and disease categories studied. Across disease categories we examined the burden of disease in the elderly in high-income countries (measured in disability-adjusted life years [DALYs]) and compared to the number of trials conducted exclusively in the elderly. RESULTS: Among 80,965 interventional trials, 1,112 (1.4%) focused on elderly patients. Diverse types of interventions were studied in these trials (medications 33%, behavioral interventions 18%, and dietary supplements 10%) and the majority was funded by non-profit organizations (81%). Studies tended to be small (median sample size 122 participants [IQR 58, 305]), single-center studies (67%). Only 43% of 126 disease categories affecting elderly persons were studied in trials focused on the elderly. Among these disease categories, there was a 5162-fold range in the ratio of DALYs per trial. Across 5 conditions where over 80% of DALYs are in the elderly, there were a total of only 117 trials done exclusively in the elderly. CONCLUSIONS: Very few and mostly small studies are conducted exclusively in elderly persons, even for conditions that affect almost exclusively the elderly.
format Online
Article
Text
id pubmed-4873036
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-48730362016-06-09 Prevalence and Characteristics of Interventional Trials Conducted Exclusively in Elderly Persons: A Cross-Sectional Analysis of Registered Clinical Trials Bourgeois, Florence T. Olson, Karen L. Tse, Tony Ioannidis, John P. A. Mandl, Kenneth D. PLoS One Research Article BACKGROUND: Elderly patients represent the greatest consumers of healthcare per capita but have historically been underrepresented in clinical trials. It is unknown how many trials are designed to focus exclusively on elderly patients. OBJECTIVE: To define the prevalence of interventional trials that study exclusively elderly persons and describe the characteristics of these trials, including their distribution across conditions most prevalent in the elderly. DESIGN: All interventional clinical trials enrolling exclusively elderly patients (≥65 years), conducted primarily in high-income countries, and initiated between 2006 and 2014, identified through ClincialTrials.gov. MAIN MEASURES: Trials were identified and characterized according to design features and disease categories studied. Across disease categories we examined the burden of disease in the elderly in high-income countries (measured in disability-adjusted life years [DALYs]) and compared to the number of trials conducted exclusively in the elderly. RESULTS: Among 80,965 interventional trials, 1,112 (1.4%) focused on elderly patients. Diverse types of interventions were studied in these trials (medications 33%, behavioral interventions 18%, and dietary supplements 10%) and the majority was funded by non-profit organizations (81%). Studies tended to be small (median sample size 122 participants [IQR 58, 305]), single-center studies (67%). Only 43% of 126 disease categories affecting elderly persons were studied in trials focused on the elderly. Among these disease categories, there was a 5162-fold range in the ratio of DALYs per trial. Across 5 conditions where over 80% of DALYs are in the elderly, there were a total of only 117 trials done exclusively in the elderly. CONCLUSIONS: Very few and mostly small studies are conducted exclusively in elderly persons, even for conditions that affect almost exclusively the elderly. Public Library of Science 2016-05-19 /pmc/articles/PMC4873036/ /pubmed/27196289 http://dx.doi.org/10.1371/journal.pone.0155948 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Bourgeois, Florence T.
Olson, Karen L.
Tse, Tony
Ioannidis, John P. A.
Mandl, Kenneth D.
Prevalence and Characteristics of Interventional Trials Conducted Exclusively in Elderly Persons: A Cross-Sectional Analysis of Registered Clinical Trials
title Prevalence and Characteristics of Interventional Trials Conducted Exclusively in Elderly Persons: A Cross-Sectional Analysis of Registered Clinical Trials
title_full Prevalence and Characteristics of Interventional Trials Conducted Exclusively in Elderly Persons: A Cross-Sectional Analysis of Registered Clinical Trials
title_fullStr Prevalence and Characteristics of Interventional Trials Conducted Exclusively in Elderly Persons: A Cross-Sectional Analysis of Registered Clinical Trials
title_full_unstemmed Prevalence and Characteristics of Interventional Trials Conducted Exclusively in Elderly Persons: A Cross-Sectional Analysis of Registered Clinical Trials
title_short Prevalence and Characteristics of Interventional Trials Conducted Exclusively in Elderly Persons: A Cross-Sectional Analysis of Registered Clinical Trials
title_sort prevalence and characteristics of interventional trials conducted exclusively in elderly persons: a cross-sectional analysis of registered clinical trials
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873036/
https://www.ncbi.nlm.nih.gov/pubmed/27196289
http://dx.doi.org/10.1371/journal.pone.0155948
work_keys_str_mv AT bourgeoisflorencet prevalenceandcharacteristicsofinterventionaltrialsconductedexclusivelyinelderlypersonsacrosssectionalanalysisofregisteredclinicaltrials
AT olsonkarenl prevalenceandcharacteristicsofinterventionaltrialsconductedexclusivelyinelderlypersonsacrosssectionalanalysisofregisteredclinicaltrials
AT tsetony prevalenceandcharacteristicsofinterventionaltrialsconductedexclusivelyinelderlypersonsacrosssectionalanalysisofregisteredclinicaltrials
AT ioannidisjohnpa prevalenceandcharacteristicsofinterventionaltrialsconductedexclusivelyinelderlypersonsacrosssectionalanalysisofregisteredclinicaltrials
AT mandlkennethd prevalenceandcharacteristicsofinterventionaltrialsconductedexclusivelyinelderlypersonsacrosssectionalanalysisofregisteredclinicaltrials